News – Page 192 – Endpoints News

Merck KGaA to focus on ‘external innovation’ as it exits BTK inhibitor race

Last year

GSK declares second PhIII win for Blenrep combo in bid to revive drug

Last year

Early-stage oncology startup Boundless Bio files for IPO

Last year

Drugmakers gear up for joint IRA arguments as PhRMA appeals Texas verdict

Last year

Sun Pharma re-enlists popular ‘Pimple Popper’ doctor for acne brand TV campaign

Last year

FDA sees success in model-informed drug development pilot

Last year

Tarsus’ eye drops interrupt an animated mite 'party’ in first DTC ad for Xdemvy

Last year

Health tech investors outline investment priorities in AI

Last year

Valisure pressures FDA to recall acne treatments after finding carcinogen

Last year

FDA faces flatlined budget as clock ticks for Congress to pass government funding

Last year

AstraZeneca allocates £650M to boost its UK manufacturing, campus footprint

Last year

As the biotech markets warm up, signs point to crossover rounds returning

Last year

Apogee's $350M offering; BiomX merges with Adaptive Phage

Last year

Third antigen's a charm: Gilead pens deal with Merus for up to three trispecific antibodies

Last year

Senate committee advances bill targeting Chinese manufacturers as BIO faces attack for backing WuXi

Last year

Federal agencies launch antitrust inquiry into transactions in healthcare

Last year

Alumis closes a $259M Series C to back its TYK2, flirts with talk about an IPO

Last year

Sumitomo to lay off about 400 employees, reshuffle execs in North America as sales disappoints

Last year

Sionna raises $182M for cystic fibrosis drugs different from Vertex's approach

Last year

Spanish VC preps launch for €100M fund with an emphasis on advanced therapies

Last year

Sen. Warren attacks GSK's decision to shift inhaler from brand to authorized generic

Last year

European Commission spells out new proposals for health technology assessments

Last year

Pfizer says IRA impact will be 'modest,' maps out R&D priority changes

Last year

Sandoz wins FDA approval for first two biosimilars for Amgen's blockbuster bone drug

Last year

First page Previous page 189 190 191192193 194 195 Next page Last page